Randy Dryer, MD, Curiteva’s CMO, performed the first clinical case using the company’s Inspire standalone ALIF system, according to a Jan. 9 news release.
The Inspire system is part of Curiteva’s anterior portfolio. It uses a PEEK structure to enhance bone growth and osseointegration.
“Bringing the Inspire Standalone ALIF across the finish line and into the operating room is a significant accomplishment,” Dr. Dryer said in the release. “As we have seen with this technology, the visual verification of bone growth through the implant, paired with outstanding clinical results, aligns perfectly with what surgeons are seeking. I’m confident this implant will define a new standard for standalone ALIF procedures, delivering a best-in-class solution designed to enhance patient outcomes.”
A commercial release for Inspire is expected later in 2026.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
